Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches
- 31 December 2009
- journal article
- Published by Elsevier BV in Journal of Molecular and Cellular Cardiology
- Vol. 47 (6), 835-845
- https://doi.org/10.1016/j.yjmcc.2009.08.017
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Orally Bioavailable Potent Soluble Epoxide Hydrolase InhibitorsJournal of Medicinal Chemistry, 2007
- Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2006
- Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile FunctionCirculation Research, 2006
- Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular FunctionCirculation Research, 2006
- Genetic variation in soluble epoxide hydrolase ( EPHX2 ) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) studyHuman Molecular Genetics, 2006
- Cardiac Hypertrophy: The Good, the Bad, and the UglyAnnual Review of Physiology, 2003
- Alterations of Sodium Channel Kinetics and Gene Expression in the Postinfarction Remodeled MyocardiumJournal of Cardiovascular Electrophysiology, 2001
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999